JAK Inhibitor Treatment in AGS

Clinical trial NCT03921554 · COMPLETED

Trial details

NCT number: NCT03921554
Sponsor: Adeline Vanderver, MD
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Aicardi Goutieres Syndrome

Start date: 2019-06-03
Primary completion: 2024-01-04
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.